Applied Genetic Technologies Corp. (AGTC) PT Lowered to $9 at Wedbush, Following Clinical Business Update
Tweet Send to a Friend
Wedbush analyst David Nierengarten lowered the price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $9.00 (from $12.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
